BlackRock »

Corbus Pharmaceuticals Hldgs shares owned by BlackRock

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 803k 20.63

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Octagon Capital Advisors
OrbiMed Advisors
BlackRock
BlackRock
Ikarian Capital
Tang Capital Management
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Morgan Stanley
Geode Capital Management
Sio Capital Management
Schonfeld Strategic Advisors

View all funds holding Corbus Pharmaceuticals Hldgs